Latest news for Atacadao (OTC:ATAAY) Stock

Atacadao SA has three operating segments. The Retail segment comprises the operations of Carrefour-branded hypermarkets, supermarkets, and convenience store formats as well as drugstores, gas stations, and e-commerce platforms for the sale of non-food goods. The Cash and Carry segment, which is the key revenue driver, comprises the operations of wholesale and cash-carry stores that operate under the Atacadao brand. The Financial Solutions segment provides credit cards and consumer financing to its customers. Substantially, all of the group's revenues are derived from operations in Brazil.

Atacadao SA

- Goldman Sachs Energy, CleanTech &amp; Utilities Conference 2025&nbsp;

News

Events

Chevron CEO Says U.S. Could See A Build Out Of Natural Gas Power Generation To Support Data Center Demand

Macro Economic Events

Economics

Federal Reserve

Fed's Waller Says Monetary Rules Are A Good Check On Judgment, But Should Not Be Used Exclusively; Filling Out The December Sep Was A Very Difficult Problem Given Policy Uncertainty

UBS analyst Jo Walton upgrades Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) from Sell to Buy.

Upgrades

Analyst Ratings

UBS Upgrades Novo Nordisk to Buy

Is Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) stock climbing on optimism or concrete signals? The stock has surged 104% over the past year, with its rally appearing to align with President-elect Donald Trump&#8216;s upcoming return to <a href="https://www.benzinga.com/topic/donald-trump">the White House.</a>
But will the momentum last?
<h2 class="wp-block-heading">Technical Tea Leaves: Bullish, With A Dash Of Bear Risk</h2>
DJT's current trend is technically strong. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08081244/Screenshot-2025-01-08-at-6.42.17-PM.png" alt="" class="wp-image-723905" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08081244/Screenshot-2025-01-08-at-6.42.17-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08081244/Screenshot-2025-01-08-at-6.42.17-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
DJT stock, at $34.50, trades above its five, 20 and 50-day exponential moving averages, signaling a bullish outlook. Key indicators paint a mixed picture:
<ul>
<li>Eight-Day SMA (simple moving average) Bearish Signal: At $34.85, it's just above the stock price, hinting at short-term bearishness.</li>
<li>20-Day SMA Bearish Signal: DJT is trading below the $35.60 level, sparking concerns about overextension.</li>
<li>50 and 200-Day SMA Bullish: At $34.22 and $33.21 respectively, these moving averages support the bullish case.</li>
<li>MACD at 0.42: Another bullish indicator, showing positive momentum.</li>
<li>RSI at 49.61: The stock isn't overheated but inching toward neutral territory, reflecting a balance of buying and selling pressure.</li>
</ul>
Still, selling pressure could soon weigh on DJT, indicating a risk of bearish movement ahead.
<h2 class="wp-block-heading">Impact Of Courtroom Battles</h2>
Tuesday saw <a href="https://www.benzinga.com/news/legal/25/01/42859160/whats-going-on-with-trump-media-technology-group-stock-on-tuesday-5">DJT stock dip slightly</a>, following a New York court denying Trump&#8217;s immunity plea in his felony case. The judge's ruling solidified Trump's Jan. 10 sentencing date, just days before his presidential inauguration on Jan. 20.
The case stems from a $130,000 hush money payment in the 2016 election cycle, with Trump already convicted of 34 felony counts for falsifying business records. 
Despite legal hurdles, Trump Media&#8217;s parent stock has remained resilient, buoyed by advertising revenue on its Truth Social platform and investor optimism about Trump's 2025 inauguration.
<h2 class="wp-block-heading">Is DJT Stock's Rally Worth Watching?</h2>
DJT's performance might feel like a rally in lockstep with Trump's political fortunes. While technical indicators lean bullish, the stock faces headwinds—court rulings, selling pressure, and recent dips hint at volatility ahead.
For investors, DJT presents a speculative opportunity worth monitoring closely, trading above key averages amid its inauguration rally, though ongoing legal and political developments add uncertainty to its trajectory.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42821003/trump-jr-invests-in-grabagun-what-investors-should-know-about-ecommerce-company-set-to-trade-as-pew">Trump Jr. Partners With GrabAGun: What Investors Should Know About E-Commerce Company Set To Trade As &#8216;PEW&#8217;</a></li>
</ul>
Image created using photos from Shutterstock.

Social Media

Technicals

Politics

Tech

Trading Ideas

General

Trump Media Stock Climbs 104%: Bullish Technicals, Inauguration Rally Drive Volatility

Goldman Sachs analyst Alex Scott maintains Synchrony Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) with a Buy and raises the price target from $72.5 to $82.

Price Target

Goldman Sachs Maintains Buy on Synchrony Finl, Raises Price Target to $82

Contracts

VISL

Vislink Technologies Partners With Radio Television Malaysia To Deploy Advanced Vislink System; Contract Worth Over $1M

NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is facing a decline in premarket trading despite positive developments for its sub-brand Onvo, which is making <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">strides in expanding its battery swap infrastructure.</a>
Onvo, aiming to enhance its services during the Chinese New Year travel rush, plans to add 1,000 additional 60-kWh battery packs to its swap stations, particularly focusing on key highway segments, <a target="_blank" href="https://cnevpost.com/2025/01/08/onvo-owners-more-batteries-free-swap-service-new-year-holidays/" rel="noreferrer noopener">reports</a> CnEV Post.
This will ensure that drivers have access to more batteries during the holiday period, with free battery swap services offered along highways. Xia Qinghua, Onvo&#8217;s vice president, shared this update through a post on the Onvo app.
Also Read:<a target="_blank" href="https://www.benzinga.com/news/legal/25/01/42865752/tesla-supplier-catl-riot-games-owner-tencent-plan-legal-action-over-pentagon-blacklist-deny-military-ties" rel="noreferrer noopener"> Tesla Supplier CATL, Riot Games Owner Tencent Plan Legal Action Over Pentagon Blacklist, Deny Military Ties</a>
In a significant milestone, NIO recently celebrated the launch of its 3,000th battery swap station in Harbin, Heilongjiang province, pushing its total to 3,003 stations across China,<a target="_blank" href="https://www.benzinga.com/25/01/42792337/whats-going-on-with-nio-stock-today" rel="noreferrer noopener"> including 949 strategically placed along highways.</a>
This expansion is crucial to support NIO&#8217;s growing electric vehicle fleet.
Additionally, NIO reported impressive sales growth for December, delivering 31,138 vehicles, a 51% increase compared to November and a <a target="_blank" href="https://www.benzinga.com/25/01/42758540/us-listed-chinese-ev-startups-clock-delivery-growth-in-december-li-auto-tops-the-chart-mona-m03-spurs-xpeng-nios-onvo-breaches-10000-monthly-delivery-milestone" rel="noreferrer noopener">72.9% year-over-year rise</a>.
A significant portion of these deliveries came from Onvo&#8217;s affordable EV brand, which includes the newly launched L60 model that began deliveries in late September.
Price Action: NIO shares are trading lower by 3.10% to $4.37 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/events/25/01/42860583/trump-floats-canada-as-51st-us-state-says-hes-ready-to-use-economic-force-to-achieve-it" target="_blank" rel="noreferrer noopener">Trump Floats Canada As 51st US State, Says He's Ready To Use ‘Economic Force' To Achieve It</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Equities

Markets

Movers

Media

What's Going On With NIO Stock Today?

Goldman Sachs analyst Eric Sheridan maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $490 to $550.

SPOT

Goldman Sachs Maintains Buy on Spotify Technology, Raises Price Target to $550

Terreno Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRNO#NYSE">TRNO</a>), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, sold an industrial property located in Union City, California on January 7, 2025 for a sale price of approximately $16.9 million.
The property consists of one industrial distribution building containing approximately 66,000 square feet on 3.0 acres which is vacant. The property was purchased by Terreno Realty Corporation on March 26, 2015 for $7.4 million. The unleveraged internal rate of return generated by the investment was 13.0%.

Asset Sales

TRNO

Terreno Realty Corporation Sells Property In Union City, CA For $16.9M

WIIM

ONDS

Ondas Holdings shares are trading higher after the company announced it secured an order from a major defense company for its AI-driven iron drone raider system.

<ul>
<li>NVDA</li>
<li>CVNA</li>
<li>RGTI</li>
<li>TSLA</li>
<li>AMD</li>
<li>PLTR</li>
<li>FUBO</li>
<li>CORN</li>
<li>META</li>
<li>X</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

CORN

CVNA

FUBO

NVDA

PLTR

RGTI

TSLA

Top 10 Trending Stocks On WallStreetBets As Of January 8, 2025 (Via Swaggy Stocks)

Blue Hat Interactive Entertainment Technology ("Blue Hat" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>), today announced that it has entered into securities purchase agreements with several institutional investors to purchase an aggregate of 55,950,000 Ordinary Shares (the "Ordinary Shares") in a registered direct offering. The Ordinary Shares are being sold at an offering price of $0.07 per share.
The gross proceeds to the Company from the registered direct offering are estimated to be approximately $3.9 million before deducting the placement agent's fees and other estimated offering expenses payable by the Company. The offering is expected to close on or about January 10, 2025, subject to the satisfaction of customary closing conditions.
Maxim Group LLC is acting as the sole placement agent in connection with the offering.

Offerings

BHAT

Blue Hat Announces Pricing Of $3.9M Registered Direct Offering  Of 55.95M Ordinary Shares At An Offering Price Of $0.07 Per Share

MBRX

Moleculin Biotech shares are trading higher after the company announced it received U.S. institutional review board approval for its Phase 3 clinical trial.

On Wednesday, Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) <a target="_blank" href="https://www.benzinga.com/topic/samsung" rel="noreferrer noopener">announced its</a> earnings guidance for the <a target="_blank" href="https://news.samsung.com/global/samsung-electronics-announces-earnings-guidance-for-fourth-quarter-2024" rel="noreferrer noopener">fourth quarter of 2024</a>.
The company expects quarterly sales of $51.38 billion (75 trillion Korean won versus 67.78 trillion Korean a year ago) and operating profit of 6.5 trillion Korean&nbsp;won (versus 2.82 trillion Korean won a year ago).
Samsung reported sales of 79.1 trillion Korean won, and operating profit of 9.18 trillion Korean won in the third quarter of 2024.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42818093/amd-and-stradvision-team-up-to-boost-adas-backed-by-trump-and-musks-vision-for-autonomous-cars" rel="noreferrer noopener">AMD, StradVision Team Up To Boost Driver Assistance Systems For Autonomous Cars</a>
The cautious operating profit guidance marks pressure from research and development costs, and the ramp-up of manufacturing capacity for advanced semiconductors to cater to Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) needs, Reuters reports.
Additionally, weakness in demand for conventional memory chips used in PCs and mobile phones also affected the profit forecast. The consensus for fourth-quarter operating profit stood at 7.7 trillion Korean won.
Lee Min-hee of BNK Investment &amp; Securities flagged to Reuters the bottoming of chip demand and competition surrounding Samsung&#8217;s significant businesses.
SK Hynix&nbsp;scored over Samsung as Nvidia&#8217;s key high-bandwidth memory (HBM) chip supplier for artificial intelligence graphics processing units (GPUs).
Reportedly, Nvidia approved Samsung&#8217;s <a target="_blank" href="https://www.benzinga.com/news/24/08/40227015/nvidia-greenlights-samsungs-fifth-gen-hbm3e-chips-for-ai-processors-report" rel="noreferrer noopener">fifth-gen HBM3E chips</a>, while the 12-layer HBM3E chips await approval. Samsung expects HBM3E chips to account for 60% of its HBM chip sales by the fourth quarter.
Prior reports indicated that SK Hynix sustained an HBM market share of over 52% in 2024, Samsung followed with 42.4%, and&nbsp;Micron Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) had over 5% of the market.
Morgan Stanley expects the HBM market to grow from $4 billion in 2023 to $71 billion in 2027.
Micron is one of <a target="_blank" href="https://www.benzinga.com/24/12/42657620/amd-and-micron-top-analyst-picks-for-ai-and-next-gen-tech-growth" rel="noreferrer noopener">Rosenblatt&#8217;s top picks</a> for the first half of 2025 despite the loss of the Chinese market due to Washington&#8217;s semiconductor sanctions on China. Micron&#8217;s loss benefits Samsung as Chinese tech companies like Huawei and Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) stockpiled <a target="_blank" href="https://www.benzinga.com/government/24/08/40198085/huawei-and-baidu-increase-samsung-hbm-purchases-as-us-curbs-loom" rel="noreferrer noopener">Samsung HBM chips</a>.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42793394/nvidias-2-trillion-ai-rally-fueled-by-chips-startups-and-robotics" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s $2 Trillion AI Rally In 2024 Fueled by Chips, Startups, and Robotics</a></li>
</ul>
Image via Shutterstock

Guidance

BIDU

SSNLF

Samsung's Outlook Dims Amid HBM Supply Struggles for Nvidia and Sluggish Consumer Chip Sales

Macquarie analyst Tim Nollen maintains Getty Images Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) with a Neutral and maintains $3.75 price target.

GETY

Macquarie Maintains Neutral on Getty Images Holdings, Maintains $3.75 Price Target

HC Wainwright &amp; Co. analyst Emily Bodnar maintains Sana Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) with a Buy and raises the price target from $8 to $11.

SANA

HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Raises Price Target to $11

Goldman Sachs analyst Eric Sheridan maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Neutral and raises the price target from $750 to $850.

NFLX

Goldman Sachs Maintains Neutral on Netflix, Raises Price Target to $850

AI drug creation company Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) to enhance its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42869877/absci-and-amd-announce-collaboration-and-strategic-investment-to-accelerate-the-future-of-ai-drug-" rel="noreferrer noopener">AI drug discovery capabilities</a>.
The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci&#8217;s advanced de novo antibody design models.
The deal also includes a $20 million private investment in public equity (PIPE) by AMD, underscoring the rising demand for AI applications in the pharmaceutical industry.
Absci aims to transform biologics development by utilizing optimized AI solutions that improve biological modeling. The partnership is expected to reduce infrastructure costs while accelerating innovation cycles.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/01/42839556/uber-and-nvidia-partner-on-ai-technology-for-autonomous-cars" rel="noreferrer noopener">Uber And NVIDIA Partner On AI Technology For Autonomous Cars</a>
AMD&#8217;s support will enable Absci to enhance its proprietary antibody design model, IgDesign1, which is the first in vitro validated inverse folding model for antibody design.
Sean McClain, Absci&#8217;s Founder and CEO, said, &#8220;AMD high-performance compute will enable us to further the development of next-generation antibody therapeutics, and we are excited about the potential that this partnership holds to accelerate the future of drug discovery.&#8221;
Price Action: ABSI shares are trading higher by 44.3% at $4.46 in premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42826372/intel-struggles-to-compete-with-amd-and-nvidia-in-data-centers-and-ai-chips" target="_blank" rel="noreferrer noopener">AMD and Nvidia Overtake Intel in Key Markets, Challenging Its Leadership</a></li>
</ul>
Photo via Shutterstock.

ABSI

INTC

Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery

Offering Beauty Products In As Fast As An Hour With Integrated Ulta Beauty Rewards And Promotional Discounts

CART

ULTA

Ulta Beauty Partners With Instacart To Launch Nationwide Same-Day Delivery From Over 1,400 Stores

NLSP

NLS Pharmaceutics shares are trading higher after the company along with Kadimastem closed half of the $1 million in financing under a securities purchase agreement with an accredited investor.

Comments

Atacadao

News

Latest news for Atacadao (OTC:ATAAY) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga